DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Yen K, Travins J, Wang F. et al.
AG-221, a first-in-class therapy targeting acute myeloid leukemia harboring oncogenic IDH2 mutations.
Cancer Discovery
7: 478-493
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.